Results 61 to 70 of about 7,522 (217)

Evaluation of variations in urine laminin-γ2 monomer in non-muscle-invasive bladder cancer before and after transurethral resection of the bladder tumor

BMC Cancer
Background We have previously reported urine laminin-γ2 monomer (Lm-γ2m) as a diagnostic biomarker for patients with non-muscle-invasive bladder cancer (NMIBC).
Kimito Osaka, Takeshi Kishida, Susumu Umemoto, Takashi Karashima, Masatoshi Nakagawa, Eisaku Yoshida, Toru Yoshimura, Masahiko Sakaguchi, Keiji Inoue, Naohiko Koshikawa, Motoharu Seiki, Taro Shuin   +11 more
doaj   +1 more source

Is There A Benefit of Restaging Transurethral Resection of Bladder Tumor Prior to Radical Cystectomy With or Without Neoadjuvant Chemotherapy?

Bladder Cancer, 2023
BACKGROUND: One of the best predictors of positive outcomes in bladder cancer (BC) is pT0 following radical cystectomy (RC). Discordance between clinical and pathologic staging affects decision-making in patients with clinical absence of disease (cT0 ...
Justin P. Mehr, Jenna N. Bates, Seth P. Lerner   +2 more
doaj   +1 more source

Simultaneous Robot‐Assisted Distal Gastrectomy and Radical Cystectomy With a Shared Port Configuration in Situs Inversus Totalis

IJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Situs inversus totalis complicates minimally invasive surgery, and simultaneous robotic surgery for tumors of different organs is particularly challenging. Case Presentation A 72‐year‐old man with situs inversus totalis receiving androgen blockade for prostate cancer developed a 40‐mm muscle‐invasive bladder tumor undetected on ...
Takaharu Hamada, Shugo Yajima, Shota Umezawa, Gaku Okumura, Tomoki Kimura, Shu Gozu, Madoka Kataoka, Yasukazu Nakanishi, Takahiro Kinoshita, Hitoshi Masuda   +9 more
wiley   +1 more source

Does Bladder Cancer with Inchworm Sign Indicate Better Prognosis after TURBT?

, 2022
Background: Inchworm sign is considered to be a characteristic finding in non-muscle invasive bladder cancer (NMIBC). Nevertheless, pathologically diagnosed muscle invasive bladder cancers (MIBCs) are occasionally diagnosed from tissue obtained by ...
Kawaguchi, Shohei, Naito, Renato, Ryunosuke Nakagawa, Takahiro Nohara, Atsushi Mizokami, Iwamoto, Hiroaki, Shigehara, Kazuyoshi, Kazuyoshi Shigehara, Izumi, Kouji, Suguru Kadomoto, Yaegashi, Hiroshi, Yoshifumi Kadono, Hiroaki Iwamoto, Kadono, Yoshifumi, Kouji Izumi, Yoshida, Kotaro, Hiroshi Yaegashi, Kadomoto, Suguru, Shohei Kawaguchi, Kotaro Yoshida, Renato Naito, Nohara, Takahiro, Mizokami, Atsushi, Nakagawa, Ryunosuke   +23 more
core   +1 more source

Primary Pure Yolk Sac Tumor of the Urinary Bladder: A Case Report

IJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Yolk sac tumors are malignant germ cell tumors that typically arise in the gonads. Although extragonadal cases have been reported, primary involvement of the urinary tract is extremely rare. Case Presentation A 67‐year‐old man presented with gross hematuria.
Yuki Hashimoto, Kosuke Shimizu, Masayuki Uegaki, Fumihiko Kono, Toru Yoshida   +4 more
wiley   +1 more source

Additional oncological benefit of photodynamic diagnosis with blue light cystoscopy in transurethral resection for primary non‐muscle‐invasive bladder cancer: A comparative study from experienced institutes

BJUI Compass, 2023
Objectives The objective of this work is to evaluate the additional oncological benefit of photodynamic diagnosis (PDD) using blue‐light cystoscopy in transurethral resection (TURBT) for primary non‐muscle‐invasive bladder cancer (NMIBC) based on the ...
Makito Miyake, Nobutaka Nishimura, Tomonori Nakahama, Koshiro Nishimoto, Masafumi Oyama, Yuto Matsushita, Hideaki Miyake, Hideo Fukuhara, Keiji Inoue, Keita Kobayashi, Hiroaki Matsumoto, Hideyasu Matsuyama, Tomomi Fujii, Yoshihiko Hirao, Kiyohide Fujimoto   +14 more
doaj   +1 more source

Symptom‐guided reduction of BCG dwell time: findings from the north‐REG randomized trial

BJU International, Volume 138, Issue 5, Page 831-840, November 2026.
Objectives To evaluate the impact of personalized dwell‐time (DT) reductions on symptom prevalence and systemic toxicities in patients undergoing Bacillus Calmette–Guérin (BCG) instillation for non‐muscle invasive bladder cancer (NMIBC). Methods Within a multinational randomized controlled trial (North‐REG Dwell Time Study [NCT04701151]), 225 patients ...
Lene Munk, Josephine Maria Hyldgaard, Vanaja Kumasegaram, Rikke Vilsbøl Milling, Simone Buchardt Brandt, Juan Luis Vásquez, Knud Fabrin, Gitte Wrist Lam, Lasse Bro, Sigurður Gudjonsson, Viveka Ströck, Tomas Jerlsström, Tomas Thiel, Maria Skydt Lindgren, Jørgen Bjerggaard Jensen, Charlotte Graugaard‐Jensen   +15 more
wiley   +1 more source

Should intravesical Bacillus Calmette-Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?

PLoS ONE, 2018
We evaluated the effect of intravesical Bacillus Calmette-Guerin (BCG) and BCG maintenance therapy on the prognosis of patients with T0 after repeat transurethral resection of bladder mass (TURBT).
Hyeong Dong Yuk, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku   +4 more
doaj   +1 more source

Efficacy and safety of transurethral resection of bladder tumour combined with chemotherapy and immunotherapy in bladder-sparing therapy in patients with T1 high-grade or T2 bladder cancer: a protocol for a randomized controlled trial

BMC Cancer, 2023
Background Bladder cancer is the tenth most common cancer worldwide. For patients with T1 high-grade or T2 bladder cancer, radical cystectomy is recommended.
Xiangwei Yang, Shiqiang Zhang, Yajiao Cui, Yamei Li, Xinyue Song, Jun Pang   +5 more
doaj   +1 more source

UCtracker: A Deep Learning–Based DNA Methylation Model for Noninvasive Diagnosis and Recurrence Surveillance of Urothelial Carcinoma in a Prospective Study

Advanced Science, Volume 13, Issue 57, 14 October 2026.
We developed UCtracker, a urine DNA methylation–based deep learning model, for noninvasive diagnosis and postoperative surveillance of urothelial carcinoma. UCtracker demonstrates high diagnostic accuracy, robustness at ultralow sequencing depth, early recurrence detection, and dynamic risk‐stratified monitoring of molecular residual disease ...
Shengwei Xiong, Gaojie Li, Yucai Wu, Yuan Liang, Heng Guo, Yu Zhang, Gengyan Xiong, Long Tian, Xin Zhang, Ye Tian, Zhengguo Ji, Bin Guo, Yue Shi, Jian Fan, Zhihua Li, Yanqing Gong, Shiming He, Xuesong Li, Weimin Ci, Liqun Zhou   +19 more
wiley   +1 more source